# Sanofi: financial statements, quarterly

SNY · Nasdaq · CIK 1121404 · [Healthcare](/sectors/healthcare.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sny.md) · [Financials](/companies/sny/financials.md) · [Filings](/companies/sny/filings.md) · [Insiders](/companies/sny/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sny/financials.md?period=annual).

## Balance sheet

| Line item | Unit | period not labelled (2014-12-31) | period not labelled (2015-12-31) | period not labelled (2016-12-31) | FY2017 (2017-12-31) | FY2018 (2018-12-31) | FY2019 (2019-12-31) | FY2020 (2020-12-31) | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [7.3](/filings/0001193125-18-084834.md) | [9.1](/filings/0001193125-19-068926.md) | [10.3](/filings/0001121404-20-000006.md) | [10.3](/filings/0001121404-21-000004.md) | [6.9](/filings/0001121404-22-000007.md) | [9.4](/filings/0001121404-23-000008.md) | [13.9](/filings/0001121404-24-000009.md) | [10.1](/filings/0001121404-25-000010.md) | [12.7](/filings/0001628280-26-008403.md) | [8.7](/filings/0001628280-26-008403.md) | [7.4](/filings/0001628280-26-008403.md) | [7.7](/filings/0001628280-26-008403.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [34.1](/filings/0001121404-25-000010.md) | [30.7](/filings/0001628280-26-008403.md) | [42.6](/filings/0001628280-26-008403.md) | [31.0](/filings/0001628280-26-008403.md) |
| Total assets | $bn | not reported | [102](/filings/0001193125-18-084834.md) | [105](/filings/0001193125-19-068926.md) | [99.8](/filings/0001121404-20-000006.md) | [111](/filings/0001121404-21-000004.md) | [113](/filings/0001121404-22-000007.md) | [114](/filings/0001121404-23-000008.md) | [120](/filings/0001121404-24-000009.md) | [127](/filings/0001121404-25-000010.md) | [126](/filings/0001628280-26-008403.md) | [133](/filings/0001628280-26-008403.md) | [127](/filings/0001628280-26-008403.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [24.0](/filings/0001121404-25-000010.md) | [24.2](/filings/0001628280-26-008403.md) | [29.2](/filings/0001628280-26-008403.md) | [28.3](/filings/0001628280-26-008403.md) |
| Shareholders' equity | $bn | [56.3](/filings/0001193125-18-084834.md) | [58.0](/filings/0001193125-18-084834.md) | [57.6](/filings/0001193125-19-068926.md) | [58.1](/filings/0001121404-20-000006.md) | [58.9](/filings/0001121404-21-000004.md) | [59.1](/filings/0001121404-22-000007.md) | [63.1](/filings/0001121404-23-000008.md) | [68.7](/filings/0001121404-24-000009.md) | [74.8](/filings/0001121404-25-000010.md) | [74.0](/filings/0001628280-26-008403.md) | [77.5](/filings/0001628280-26-008403.md) | [71.4](/filings/0001628280-26-008403.md) |

- Cash and equivalents: ifrs-full:CashAndCashEquivalents
- Current assets: ifrs-full:CurrentAssets
- Total assets: ifrs-full:Assets
- Current liabilities: ifrs-full:CurrentLiabilities
- Shareholders' equity: ifrs-full:Equity, ifrs-full:EquityAttributableToOwnersOfParent

Shares outstanding: 1,219,427,096 at 2025-12-31, from the cover of the [20-F filed 2026-02-17](/filings/0001628280-26-008403.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:33 ET. No prices; not investment advice.